65,437 trials
Acellular Pertussis · Tetanus · Diphtheria
Primary: Anti-diphtheria (Anti-D) and Anti-tetanus (Anti-T) Antibody Concentrations — 9.207; 21.393; 12.527; 11.07 IU/mL
Breast Neoplasms
Primary: Percentage of Participants With At Least 1 Adverse Event (AE) During the Treatment Period — 88.6; 89.0 percentage of participants
Post Traumatic Stress Disorder
Primary: Mean Baseline Startle Magnitude During Fear Conditioning — 48.401; 56.595; 115.778; 57.684 microvolts
Preterm Infants · Dolichocephaly · Positional Scaphocephaly
Primary: Cranial Index (CI) — 79 cranial index
Fragile X Syndrome
Primary: Aberrant Behavior Checklist — 7.1; 15.6; 9.6; 7.6 units on a scale
Relapsing-Remitting Multiple Sclerosis
Primary: Number of Participants Who Utilized Symptomatic Therapy With Gastrointestinal-Related Events During the 12-Week Treatment Period: Modified Overall Gastrointestinal…
Schizo-affective Disorder · Bipolar Disorder
Primary: Positive and Negative Symptom Scores at Baseline and at 2 Weeks, 4 Weeks, and 6 Weeks During Intervention 1 (Glycine or Placebo), Intervention 2 (Glycine or Placebo)…
Type 1 Diabetes
Primary: Change in A1C — -0.5 Percent
Colorectal Cancer · Colorectal Carcinoma · Colon Cleansing
Primary: Number of Patients With Successful Bowel Cleansing (Overall Colon) — 135; 155; 116; 95 Participants — p=0.038
Paranoia · Schizophrenia · Schizoaffective Disorder
Primary: Emotion Recognition as Measured by the Emotion Recognition-40 at the 6 Week Time Point — 7.25; 6.67; 4.38; 6.17 number of correct responses — p=.61
Refractory Multiple Myeloma · Stage I Multiple Myeloma · Stage II Multiple Myeloma
Primary: Response Rate, Defined as the Number of Patients Achieving Complete Response (CR), Partial Response (PR), or Minor Response (MR) — 5; 2; 3; 1 Participants
Influenza, Human
Primary: The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. — 1.01; 1.05; 0.89; 0.92 Ratio
Alcohol Dependence
Primary: Measure the Maximum (Peak) Plasma Concentration of the Drug (Cmax) — 8.88 ng/mL
HIV
Primary: Change in Flow-mediated, Endothelium-dependent Vasodilation — 0.2; 0.8 percentage vasodilation
Osteoporosis
Primary: Percent Change From Baseline in Femoral Neck Bone Mineral Density (BMD) at Month 24 — 1.73; -0.94 Percent Change — p=<0.001